Humana (HUM) Cuts Full-Year Outlook Again on Medicare Star Ratings Pressure
What happened
Humana issued a second guidance reduction, citing deteriorating Medicare Advantage star ratings that limit the insurer's reimbursement pool heading into the next plan year. Lower star ratings directly compress per-member payment rates from the Centers for Medicare and Medicaid Services. The revision marks at least the second material downward adjustment to HUM's forward outlook within a recent reporting cycle, signaling persistent structural headwinds in the company's core Medicare business segment.
The QL Read
HUM is down 6.78% on the session against a broadly negative tape, with market breadth at 34% advancing and 353 Strong Sells flagged market-wide. The composite signal reads 64/100 (Buy), a level that predates today's guidance revision and may lag any repositioning that follows.